Hoth Therapeutics, Inc. has entered into a sponsored research agreement with GW to explore the potential use of Aprepitant for topical and/or systemic therapy to counter the dermatological related side-effects of Erlotinib therapy in cancer patients.
Congratulations to Dara Baker, third-year MD student at the George Washington University School of Medicine and Health Sciences (SMHS), who was named as a fellow in the National Institutes of Health’s (NIH) 2019–20 Medical Research Scholars Program (MRSP).
A recent survey found patients with psoriasis frequently use complementary or alternative therapies to treat their symptoms
Cherinne Arundel, MD; Gurusher Panjrath, MD; Charles Faselis, MD; Richard M. Allman, MD; and Ali Ahmed, MD, MPH, all of SMHS, authored a study finding that patients with heart failure who have a systolic blood pressure less than 130 mmHg are at a higher risk of worse outcomes.
“Incorporating the Arts to Improve the Health and Wellbeing of Washington, D.C.” brought out community leaders and clinicians to the 6th Annual Rodham Institute Summit.
Third-year medical students kicked off their final Clinical Public Health Summit with a panel and presentations by graduating fourth-year students.